. To get close to that goal, specialists say, Truvada for PrEP needs to be far more widespread. Trump’s newest budget, released this month, would add $291 million to fight the disease.
After Truvada was shown to work as a prophylactic in primates, the CDC applied for its patents. That began a nine-year effort, using two outside law firms retained by the CDC, which made their case to U.S. Patent and Trademark Office examiners. Gilead often works in cooperation with federal research agencies because it seeks to develop drugs to fight infectious diseases such as HIV/AIDS, hepatitis B and hepatitis C, epidemics that have attracted intense government attention. But it also has been criticized for excessive pricing; in 2013, it sparked an uproar when it priced a 12-week course of theHIV/AIDS activists have been upset about the price of Truvada for PrEP for years.
The CDC waged a successful defense of its patent in Europe, strengthening its case that its patents are legitimate, Morten said. Gilead’s Truvada patent expires in 2021; it could be at least two more years before Gilead faces lower-cost competition in the United States.
These drug companies are full of crap. We are the only country where methemphetamines are legal. Believe me, Evening Primrose Oil and Birth Control! Medication that already works! There are no cats in America!
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WSJ - 🏆 98. / 63 Read more »
Source: BuzzFeed - 🏆 730. / 51 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »